Data gathered: December 12
AI Stock Analysis - CVRx (CVRX)
Analysis generated November 21, 2024. Powered by Chat GPT.
CVRx, a medtech company, is primarily involved in the development and commercialization of innovative neuromodulation solutions for treating cardiovascular diseases. The company's flagship product, Barostim, uses baroreflex activation therapy to address heart failure and high blood pressure. Barostim has received significant recognition in the medical community for its effectiveness and unique approach, setting CVRx apart in the competitive cardiovascular treatment space.
Stock Alerts - CVRx (CVRX)
 |
CVRx | December 10 Price is up by 5.9% in the last 24h. |
|
CVRx | December 9 Price is up by 5.1% in the last 24h. |
|
CVRx | December 5 Price is down by -6% in the last 24h. |
|
CVRx | November 25 Price is up by 5.6% in the last 24h. |
Alternative Data for CVRx
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 13 | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 7,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | 13 | Sign up | Sign up | Sign up |
| Patents | 15 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 3 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,587 | Sign up | Sign up | Sign up |
| Instagram Followers | 371 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 717 | Sign up | Sign up | Sign up |
| Twitter Followers | 947 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,650 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 86 | Sign up | Sign up | Sign up |
| Linkedin Employees | 245 | Sign up | Sign up | Sign up |
About CVRx
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.
| Price | $13.61 |
| Target Price | Sign up |
| Volume | 92,240 |
| Market Cap | $331M |
| Year Range | $6.49 - $19.2 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical Devices |
In the news
 |
Canaccord Genuity Group Increases CVRx (NASDAQ:CVRX) Price Target to $22.00December 9 - ETF Daily News |
 |
Research Analysts Set Expectations for CVRx FY2024 EarningsDecember 5 - ETF Daily News |
 |
Cvrx (CVRX) Declined Due To Turbulence In The Direct Sales TeamNovember 25 - Yahoo |
 |
CVRx chief marketing officer Paul Verrastro sells $19,416 in stock By Investing.comNovember 21 - Investing.com |
 |
CVRx to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 20 - Yahoo |
|
CVRx, Inc. (NASDAQ:CVRX) Receives $15.83 Consensus PT from BrokeragesNovember 19 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 13M | 2.2M | 11M | -13M | -16M | -0.570 |
| Q2 '24 | 12M | 1.9M | 9.9M | -14M | -14M | -0.650 |
| Q1 '24 | 11M | 1.6M | 9.2M | -22M | -22M | -1.040 |
| Q4 '23 | 11M | 1.7M | 9.6M | -9.2M | -8.4M | -0.440 |
| Q3 '23 | 11M | 1.7M | 8.8M | -9M | -8.5M | -0.430 |
Insider Transactions View All
| VERRASTRO PAUL filed to sell 1,875 shares at $13.6. November 21 '24 |
| SLATTERY JOSEPH P filed to buy 30,645 shares at $8.1. August 15 '24 |
| SLATTERY JOSEPH P filed to buy 27,645 shares at $8.2. August 8 '24 |
| SLATTERY JOSEPH P filed to buy 24,645 shares at $9.1. August 6 '24 |
| Hykes Kevin filed to buy 30,000 shares at $8.4. August 5 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$90.56 0% | 49 |
 |
Edwards LifesciencesEW |
$73.81 0% | 37 |
 |
Intuitive SurgicalISRG |
$543.6 0% | 75 |
 |
MedtronicMDT |
$82.92 0% | 54 |
 |
StrykerSYK |
$376.16 0% | 48 |
Read more about CVRx (CVRX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of CVRx?
The Market Cap of CVRx is $331M.
What is the current stock price of CVRx?
Currently, the price of one share of CVRx stock is $13.61.
How can I analyze the CVRX stock price chart for investment decisions?
The CVRX stock price chart above provides a comprehensive visual representation of CVRx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling CVRx shares. Our platform offers an up-to-date CVRX stock price chart, along with technical data analysis and alternative data insights.
Does CVRX offer dividends to its shareholders?
As of our latest update, CVRx (CVRX) does not offer dividends to its shareholders. Investors interested in CVRx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of CVRx?
Some of the similar stocks of CVRx are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.